34.48

1.26% 0.43

After Hours: 34.65 0.17 +0.49%

Harmony Biosciences Holdings Inc (HRMY)

Overview News Price History Option Chain Financials Why HRMY Down? Discussions Forecast

Harmony Biosciences Holdings Inc stock is traded at $34.48, with a volume of 396.57K. It is up +1.26% in the last 24 hours and up +17.00% over the past month. Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Previous Close:

$34.05

Open:

$34.05

24h Volume:

396.57K

Relative Volume:

0.57

Market Cap:

$1.98B

Revenue:

$681.88M

Net Income/Loss:

$122.63M

P/E Ratio:

16.34

EPS:

2.11

Net Cash Flow:

$220.18M

1W Performance:

+0.91%

1M Performance:

+17.00%

6M Performance:

-0.55%

1Y Performance:

+19.43%

1-Day Range:

$33.66

$34.61

1-Week Range:

$33.47

$35.34

52-Week Range:

$26.47

$41.61

Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile

Name

Harmony Biosciences Holdings Inc

Sector

Healthcare (1178)

Industry

Biotechnology (671)

Phone

(484) 539-9800

Address

630 W GERMANTOWN PIKE, PLYMOUTH MEETING

Employee

268

Twitter

Next Earnings Date

2024-10-29

Latest SEC Filings

HRMY's Discussions on Twitter

Compare HRMY with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HRMY Harmony Biosciences Holdings Inc	34.48	1.96B	681.88M	122.63M	220.18M	2.11
ONC Beone Medicines Ltd Adr	245.58	25.81B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	441.85	111.46B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.35	40.37M	0	0	0	0.00
VRNA Verona Pharma Plc Adr	81.16	6.19B	0	-153.72M	-103.81M	-2.00
REGN Regeneron Pharmaceuticals Inc	489.52	64.44B	14.09B	4.50B	2.96B	39.28

Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-11-25	Initiated	Deutsche Bank	Buy
Dec-17-24	Initiated	H.C. Wainwright	Buy
Oct-10-24	Resumed	Raymond James	Outperform
Sep-10-24	Initiated	UBS	Buy
Jun-21-24	Initiated	Citigroup	Buy
Jan-02-24	Downgrade	BofA Securities	Neutral → Underperform
Sep-25-23	Downgrade	Goldman	Neutral → Sell
Sep-07-23	Initiated	Berenberg	Buy
Apr-20-23	Initiated	BofA Securities	Neutral
Oct-14-22	Upgrade	Janney	Neutral → Buy
Oct-14-22	Upgrade	Jefferies	Hold → Buy
Aug-03-22	Downgrade	Jefferies	Buy → Hold
Jul-13-22	Downgrade	Goldman	Buy → Neutral
Jul-07-22	Initiated	Mizuho	Buy
Apr-14-22	Initiated	Cantor Fitzgerald	Overweight
Dec-01-21	Initiated	Oppenheimer	Outperform
Nov-04-21	Initiated	Raymond James	Outperform
Sep-23-21	Initiated	Needham	Buy
Mar-29-21	Upgrade	Goldman	Neutral → Buy
Sep-14-20	Initiated	Goldman	Neutral
Sep-14-20	Initiated	Jefferies	Buy
Sep-14-20	Initiated	Piper Sandler	Overweight

View All

Harmony Biosciences Holdings Inc Stock (HRMY) Latest News

07:31 AM

Nuveen Asset Management LLC Buys 8,193 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World

07:31 AM

May 28, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World

May 28, 2025

May 27, 2025

Bank of America Corp DE Decreases Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World

May 27, 2025

Ameriprise Financial Inc. Purchases 18,730 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World

May 27, 2025

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of “Buy” by Analysts - Defense World

May 27, 2025

May 23, 2025

When (HRMY) Moves Investors should Listen - news.stocktradersdaily.com

May 23, 2025

May 22, 2025

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Deutsche Bank AG - Defense World

May 22, 2025

May 20, 2025

A Piece Of The Puzzle Missing From Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) 26% Share Price Climb - simplywall.st

May 20, 2025

May 18, 2025

BNP Paribas Financial Markets Invests $2.03 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World

May 18, 2025

Harmony Biosciences (NASDAQ:HRMY) Price Target Raised to $48.00 - Defense World

May 18, 2025

May 16, 2025

The Manufacturers Life Insurance Company Acquires 2,144 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World

May 16, 2025

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock Position Increased by Northern Trust Corp - Defense World

May 16, 2025

Comerica Bank Acquires 2,919 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World

May 16, 2025

Harmony Biosciences (NASDAQ:HRMY) Upgraded at Cantor Fitzgerald - Defense World

May 16, 2025

May 15, 2025

Harmony Biosciences (HRMY): Mizuho Raises Price Target to $48 | - GuruFocus

May 15, 2025

Harmony Biosciences (HRMY): Mizuho Raises Price Target to $48 | HRMY Stock News - GuruFocus

May 15, 2025

Mizuho raises Harmony Biosciences stock target to $48 - Investing.com

May 15, 2025

Harmony Biosciences (HRMY) Sees Price Target Increase Following Positive Q1 Results | HRMY Stock News - GuruFocus

May 15, 2025

Mizuho raises Harmony Biosciences stock target to $48 By Investing.com - Investing.com India

May 15, 2025

Mizuho Raises Price Target on Harmony Biosciences to $48 From $44, Keeps Outperform Rating - marketscreener.com

May 15, 2025